Cite
HARVARD Citation
Mu, R. et al. (2022). A Bayesian phase I/II platform design for co‐developing drug combination therapies for multiple indications. Statistics in medicine. pp. 374-389. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mu, R. et al. (2022). A Bayesian phase I/II platform design for co‐developing drug combination therapies for multiple indications. Statistics in medicine. pp. 374-389. [Online].